Both in Biotechnology
Elutia vs eXoZymes
Over the past year ELUT returned −13.0% and EXOZ returned −64.9%; their daily moves had a correlation of 0.03.
ELUT −13.0% EXOZ −64.9%Growth of $1, one year, split-adjusted
| Metric | ELUT | EXOZ |
|---|---|---|
| Price | $0.8132 | $4.75 |
| Market cap | $36.0M | $44.2M |
| Today | −0.95% | +5.09% |
| 1 month | −1.0% | −13.9% |
| 6 months | −16.7% | −52.0% |
| Year to date | +17.4% | −56.4% |
| 1 year | −10.6% | — |
| Revenue growth (YoY) | −11.6% | — |
| Gross margin | 59.6% | — |
| Net margin | −315.0% | — |
| P/E (TTM) | 0.7× | — |
| Price / sales | 3.0× | — |
| Net cash | $19.9M | $5.6M |
| Dividend yield | — | — |
| Volatility (60d) | 60.8% | 74.8% |
| Short % of float | 0.0% | 0.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).